66yoM | MCI, type 1 (inflammatory) | 3/4 | Marked subjective improvement, hippocampal volume increase 17th->75th %ile |
69yoM | AD, type 2 (atrophic) | 3/4 | Marked subjective improvement, quantitative neuropsychological testing improvement |
49yoF | MCI, type 2 (and possibly type 3 (toxic)) | 4/4 | Marked subjective improvement, neuropsychological testing improvement |
49yoF | MCI, type 2 | 2/4 | Marked subjective improvement, neuropsychological testing improvement |
55yoF | MCI, type 2 | 4/4 | Marked subjective improvement, neuropsychological testing improvement |
74yoM | AD, type 1 | 4/4 | Subjective improvement, MMSE 23->30 |
62yoM | AD, type 1.5 (glycotoxic) | 4/4 | Subjective improvement, MMSE 22->29 |
68yoM | MCI, type 1.5 | 3/4 | Subjective improvement, neuropsychological testing improvement |
54yoF | AD, type 3 | 3/3 | Clear subjective improvement, MoCA 19->21 |
54yoF | MCI, type 2 | 4/4 | Subjective improvement, neuropsychological testing improvement |